159 related articles for article (PubMed ID: 37142988)
1. Association between type of drinking water and upper gastrointestinal cancer incidence in the Linxian General Population.
Yang H; Wang JB; Wang XK; Fan JH; Qiao YL
BMC Cancer; 2023 May; 23(1):397. PubMed ID: 37142988
[TBL] [Abstract][Full Text] [Related]
2. Combined risk factors and risk of upper gastrointestinal cancer mortality in the Linxian general population.
Yang H; Wang XK; Wang JB; Zhao FH; Fan JH; Qiao YL; Taylor PR; Abnet CC
Int J Cancer; 2022 Nov; 151(9):1462-1473. PubMed ID: 35689438
[TBL] [Abstract][Full Text] [Related]
3. Family History and Risk of Upper Gastrointestinal Cancer in the Linxian General Population.
Yang H; Wang JB; Zhang JY; Fan JH; Qiao YL; Taylor PR
Front Oncol; 2021; 11():605106. PubMed ID: 34123779
[TBL] [Abstract][Full Text] [Related]
4. Body mass index and risk of upper gastrointestinal cancer: A 30-year follow-up of the Linxian dysplasia nutrition intervention trial cohort.
Zhang S; Wang JB; Yang H; Fan JH; Qiao YL; Taylor PR
Cancer Epidemiol; 2020 Apr; 65():101683. PubMed ID: 32045872
[TBL] [Abstract][Full Text] [Related]
5. Fresh fruit consumption may decrease the long-term risk of esophageal cancer mortality: A 30-year follow-up study in the Linxian Dysplasia Nutrition Intervention trial (NIT).
Yang H; Zhang S; Yan H; Wang J; Fan J; Qiao Y; Taylor PR
Thorac Cancer; 2020 Jul; 11(7):1918-1926. PubMed ID: 32469462
[TBL] [Abstract][Full Text] [Related]
6. The Association Between Family History of Upper Gastrointestinal Cancer and the Risk of Death from Upper Gastrointestinal Cancer-based on Linxian Dysplasia Nutrition Intervention Trial (NIT) Cohort.
Sun WY; Yang H; Wang XK; Fan JH; Qiao YL; Taylor PR
Front Oncol; 2022; 12():897534. PubMed ID: 35756616
[TBL] [Abstract][Full Text] [Related]
7. Prospective study of risk factors for esophageal and gastric cancers in the Linxian general population trial cohort in China.
Tran GD; Sun XD; Abnet CC; Fan JH; Dawsey SM; Dong ZW; Mark SD; Qiao YL; Taylor PR
Int J Cancer; 2005 Jan; 113(3):456-63. PubMed ID: 15455378
[TBL] [Abstract][Full Text] [Related]
8. Association between oral leukoplakia and upper gastrointestinal cancers: a 28-year follow-up study in the Linxian General Population Trial.
Fan JH; Wang JB; Qu CX; Zhang YQ; Taylor PR; Abnet CC; Dawsey SM; Qiao YL
Oral Oncol; 2014 Oct; 50(10):971-5. PubMed ID: 25132090
[TBL] [Abstract][Full Text] [Related]
9. Oral leukoplakia and the long-term risk of upper gastrointestinal cancer deaths in the Linxian dysplasia population.
Yang H; Zhang S; Wang J; Fan J; Qiao Y; Taylor PR
Thorac Cancer; 2020 Oct; 11(10):2804-2811. PubMed ID: 32808454
[TBL] [Abstract][Full Text] [Related]
10. Association between oral leukoplakia and risk of upper gastrointestinal cancer death: A follow-up study of the Linxian General Population Trial.
Liang H; Yang Z; Wang JB; Yu P; Fan JH; Qiao YL; Taylor PR
Thorac Cancer; 2017 Nov; 8(6):642-648. PubMed ID: 28929584
[TBL] [Abstract][Full Text] [Related]
11. Body mass index and risk of gastric cancer: A 30-year follow-up study in the Linxian general population trial cohort.
Fan JH; Wang JB; Wang SM; Abnet CC; Qiao YL; Taylor PR
Cancer Sci; 2017 Aug; 108(8):1667-1672. PubMed ID: 28594442
[TBL] [Abstract][Full Text] [Related]
12. Association between tooth loss and upper gastrointestinal cancer: A 30-year follow-up of the Linxian Dysplasia Nutrition Intervention Trial Cohort.
Zhang S; Yu P; Wang JB; Fan JH; Qiao YL; Taylor PR
Thorac Cancer; 2019 Apr; 10(4):966-974. PubMed ID: 30883021
[TBL] [Abstract][Full Text] [Related]
13. Mortality after multivitamin supplementation: Nearly 35-year follow-up of the randomized Linxian Dysplasia Nutrition Intervention Trial.
Fan JH; Wang JB; Yang H; Dawsey SM; Taylor PR; Qiao YL; Abnet CC
Cancer; 2022 Aug; 128(15):2939-2948. PubMed ID: 35670139
[TBL] [Abstract][Full Text] [Related]
14. Prevention of esophageal cancer: the nutrition intervention trials in Linxian, China. Linxian Nutrition Intervention Trials Study Group.
Taylor PR; Li B; Dawsey SM; Li JY; Yang CS; Guo W; Blot WJ
Cancer Res; 1994 Apr; 54(7 Suppl):2029s-2031s. PubMed ID: 8137333
[TBL] [Abstract][Full Text] [Related]
15. Short-term and long-term effect of nutrition intervention in the Linxian Dysplasia Nutrition Intervention Trial and the reason for disappearance of the intervention effect: A cohort study.
Fan JH; Sun WY; Yang H; Wang XK; Abnet CC; Qiao YL
Cancer; 2023 Aug; 129(15):2360-2372. PubMed ID: 37243894
[TBL] [Abstract][Full Text] [Related]
16. Nutrition intervention trials in Linxian, China: multiple vitamin/mineral supplementation, cancer incidence, and disease-specific mortality among adults with esophageal dysplasia.
Li JY; Taylor PR; Li B; Dawsey S; Wang GQ; Ershow AG; Guo W; Liu SF; Yang CS; Shen Q
J Natl Cancer Inst; 1993 Sep; 85(18):1492-8. PubMed ID: 8360932
[TBL] [Abstract][Full Text] [Related]
17. Prospective study of serum selenium levels and incident esophageal and gastric cancers.
Mark SD; Qiao YL; Dawsey SM; Wu YP; Katki H; Gunter EW; Fraumeni JF; Blot WJ; Dong ZW; Taylor PR
J Natl Cancer Inst; 2000 Nov; 92(21):1753-63. PubMed ID: 11058618
[TBL] [Abstract][Full Text] [Related]
18. Population-based case-control study on risk factors for esophageal cancer in five high-risk areas in China.
Sun X; Chen W; Chen Z; Wen D; Zhao D; He Y
Asian Pac J Cancer Prev; 2010; 11(6):1631-6. PubMed ID: 21338208
[TBL] [Abstract][Full Text] [Related]
19. Serum ghrelin and esophageal and gastric cancer in two cohorts in China.
Pritchett NR; Maziarz M; Shu XO; Kamangar F; Dawsey SM; Fan JH; Ji BT; Gao YT; Xiang YB; Qiao YL; Li H; Yang G; Wang SM; Stanczyk FZ; Chow WH; Katki HA; Zheng W; Lan Q; Freedman ND; Rothman N; Abnet CC; Murphy G
Int J Cancer; 2020 May; 146(10):2728-2735. PubMed ID: 31351006
[TBL] [Abstract][Full Text] [Related]
20. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
